An improved F98 glioblastoma rat model to evaluate novel treatment strategies incorporating the standard of care
Main Authors: | Velislava Zoteva, Valerie De Meulenaere, Marthe De Boeck, Christian Vanhove, Luc Leybaert, Robrecht Raedt, Leen Pieters, Anne Vral, Tom Boterberg, Karel Deblaere |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760731/?tool=EBI |
Similar Items
-
Integrating and optimizing tonabersat in standard glioblastoma therapy: A preclinical study.
by: Velislava Zoteva, et al.
Published: (2024-01-01) -
Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model
by: Jeroen Verhoeven, et al.
Published: (2019-05-01) -
In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
by: Valerie De Meulenaere, et al.
Published: (2020-01-01) -
Comparison of In Vivo and Ex Vivo Magnetic Resonance Imaging in a Rat Model for Glioblastoma-Associated Epilepsy
by: Charlotte Bouckaert, et al.
Published: (2021-07-01) -
The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review
by: Sam Donche, et al.
Published: (2019-01-01)